Amsterdam/Utrecht, 4 April 2023 – Holland Capital sells its stake in Valori to Cerios.
Valori believes that embedding integral quality into IT systems is crucial to allow carefree innovation. The Quality Assurance and Test Consultants of Valori build towards the quality of IT systems in all stages of software development: Building IT Quality. Valori has been doing this for over 33 years with Quality Assurance advisory, expert services and proprietary technology solutions. The eventual goal is to bring software faster into production with better and more sustainable quality.
Growth through buy and build
Holland Capital has been an active shareholder of Valori since 2019. Over the last 4 years, they have supported the team of Jaap Merkus vigorously to improve the strategic positioning of the business and to further professionalise the organisation. The buy and build strategy of Valori led to 2 takeovers. As a result, Valori could offer its clients a uniquely integrated quality solution.
Ewout Prins, managing partner at Holland Capital: “We’re very proud that we had the opportunity to embark on this journey with Valori over the past 4 years where we could help realise their growth ambitions. The acquisition by Cerios will allow Valori to enter into a new chapter of its development.”
Jaap Merkus, CEO Valori: “Valori managed to realise a unique acceleration in achieving its ambitions thanks to the close collaboration with Holland Capital. Targeted acquisitions and solid entrepreneurship were at the centre of that. That is why we are ready for the next chapter where we will join Cerios, supported by Avedon. In collaboration with Cerios we will be able to realise the next stage of growth for our clients.”
Next stage of growth for Cerios
The new brand Cerios will bring together the flagship businesses Salves, De Agile Testers Quality Accelerators and Valori into one ‘House of Brands’. This will allow them to gain a leading position in the consolidating market of quality and software testing. Through this collaboration the companies create more opportunities for consultants and a broader offering for their clients while maintaining their proper identity and autonomy.
About Holland Capital
Over the past 40 years Holland Capital has responsibly and successfully invested in more than 160 SMEs. With a clear investment strategy Holland Capital is active in the attractive growth markets of healthcare, technology and food & agri. Holland Capital’s experienced, entrepreneurial and committed investment team aims to establish an open, sustainable and professional relationship with the companies it invests in with the common goal of achieving growth. Holland Capital is backed by a broad network of successful entrepreneurs.
Abilia acquires portfolio company LivAssured
Abilia, a subsidiary of MedCap AB (publ) and part of Business Area Assistive Tech, has signed an agreement to acquire Holland Capital’s portfolio company LivAssured B.V.
Supply Chain Group and More Optimal Merge to Deliver Stronger End-to-End Supply Chain Solutions
Our portfolio company Supply Chain Group (consisting of Chainresult and Supply Chain Company) announced their merger with software company More Optimal
Actuals secures €3 million in Series A funding round led by Holland Capital
Actuals, a Dutch fintech that helps finance teams process millions of transactions without errors, has raised €3 million in a funding round led by investment firm Holland Capital.
Holland Capital announces acquisition of HealthConnected by software company Visma
Investment firm Holland Capital, active in Healthcare and Technology in the Benelux and Germany, today announces the sale of its portfolio company HealthConnected to software company Visma.
Hubert and Ewout celebrate 25 years at Holland Capital – A milestone in entrepreneurial investing
Hubert and Ewout Celebrate 25 Years at Holland Capital – A Milestone in Entrepreneurial Investing. This month, we celebrate a memorable milestone: Hubert Verbeek and Ewout Prins joined Holland Capital 25 years ago. A remarkable achievement we are proud to celebrate.
Holland Capital invests in Medexs and Van Vliet Healthcare
Holland Capital invests in Medexs and Van Vliet Healthcare, two renowned companies that support hospitals and clinics with a wide range of technological expertise, products, and services.

Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 311 94 11
Düsseldorf
Inselstraße 34
40479 Düsseldorf
+49 (0) 211 43 63 69 01